https://lipidbank.jp/mediawiki/index.php?action=history&feed=atom&title=LBF20210PG01 LBF20210PG01 - Revision history 2026-04-30T18:11:19Z Revision history for this page on the wiki MediaWiki 1.43.0 https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53259&oldid=prev Editor at 11:14, 2 November 2010 2010-11-02T11:14:19Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 20:14, 2 November 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-<del style="font-weight: bold; text-decoration: none;">Oxo</del>-<del style="font-weight: bold; text-decoration: none;">15R</del>-<del style="font-weight: bold; text-decoration: none;">hydroxy-prostsa- (</del>10<del style="font-weight: bold; text-decoration: none;">,trans-13</del>) -<del style="font-weight: bold; text-decoration: none;">dien-1-oic </del>acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9<ins style="font-weight: bold; text-decoration: none;">,15</ins>-<ins style="font-weight: bold; text-decoration: none;">Dioxo</ins>- <ins style="font-weight: bold; text-decoration: none;">(cis</ins>-<ins style="font-weight: bold; text-decoration: none;">5,</ins>10) -<ins style="font-weight: bold; text-decoration: none;">prostadienoic </ins>acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;<del style="font-weight: bold; text-decoration: none;">13</del>,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;9-<del style="font-weight: bold; text-decoration: none;">Oxo-15R-hydroxy-prostsa</del>- (10<del style="font-weight: bold; text-decoration: none;">,13E</del>) -<del style="font-weight: bold; text-decoration: none;">dien-1-oic </del>acid&amp;&amp;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;<ins style="font-weight: bold; text-decoration: none;">113</ins>,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;9<ins style="font-weight: bold; text-decoration: none;">,15</ins>-<ins style="font-weight: bold; text-decoration: none;">Dioxo</ins>- (<ins style="font-weight: bold; text-decoration: none;">5Z,</ins>10) -<ins style="font-weight: bold; text-decoration: none;">prostadienoic </ins>acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53258&oldid=prev Editor at 08:53, 21 October 2010 2010-10-21T08:53:20Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:53, 21 October 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-Oxo-15R-hydroxy-prostsa- (10,13<del style="font-weight: bold; text-decoration: none;">-trans</del>) -dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-Oxo-15R-hydroxy-prostsa- (10,<ins style="font-weight: bold; text-decoration: none;">trans-</ins>13) -dien-1-oic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;9-Oxo-15R-hydroxy-prostsa- (10,13E) -dien-1-oic acid&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;9-Oxo-15R-hydroxy-prostsa- (10,13E) -dien-1-oic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td></tr> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53257&oldid=prev Editor at 03:33, 7 September 2010 2010-09-07T03:33:18Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 12:33, 7 September 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-Oxo-15R-hydroxy-prostsa- (<del style="font-weight: bold; text-decoration: none;">5-cis</del>,13-trans) -dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-Oxo-15R-hydroxy-prostsa- (<ins style="font-weight: bold; text-decoration: none;">10</ins>,13-trans) -dien-1-oic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;9-Oxo-15R-hydroxy-prostsa- (<del style="font-weight: bold; text-decoration: none;">5Z</del>,13E) -dien-1-oic acid&amp;&amp;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;9-Oxo-15R-hydroxy-prostsa- (<ins style="font-weight: bold; text-decoration: none;">10</ins>,13E) -dien-1-oic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53256&oldid=prev Editor at 03:28, 7 September 2010 2010-09-07T03:28:54Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 12:28, 7 September 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-Oxo-15R-hydroxy-prostsa- (<del style="font-weight: bold; text-decoration: none;">10</del>-cis,13-trans) -dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-Oxo-15R-hydroxy-prostsa- (<ins style="font-weight: bold; text-decoration: none;">5</ins>-cis,13-trans) -dien-1-oic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;9-Oxo-15R-hydroxy-prostsa- (<del style="font-weight: bold; text-decoration: none;">10Z</del>,13E) -dien-1-oic acid&amp;&amp;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;9-Oxo-15R-hydroxy-prostsa- (<ins style="font-weight: bold; text-decoration: none;">5Z</ins>,13E) -dien-1-oic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53255&oldid=prev Editor at 07:14, 27 May 2010 2010-05-27T07:14:46Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:14, 27 May 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-Oxo-15R-hydroxy-prostsa-10,<del style="font-weight: bold; text-decoration: none;">13E</del>-dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-Oxo-15R-hydroxy-prostsa- <ins style="font-weight: bold; text-decoration: none;">(</ins>10<ins style="font-weight: bold; text-decoration: none;">-cis</ins>,<ins style="font-weight: bold; text-decoration: none;">13-trans) </ins>-dien-1-oic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2<ins style="font-weight: bold; text-decoration: none;">&amp;&amp;9-Oxo-15R-hydroxy-prostsa- (10Z,13E) -dien-1-oic acid</ins>&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53254&oldid=prev Editor at 05:13, 23 April 2010 2010-04-23T05:13:31Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 14:13, 23 April 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1729</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-<del style="font-weight: bold; text-decoration: none;">oxo</del>-15R-hydroxy-prostsa-10,13E-dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-<ins style="font-weight: bold; text-decoration: none;">Oxo</ins>-15R-hydroxy-prostsa-10,13E-dien-1-oic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td></tr> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53253&oldid=prev Editor at 21:00, 14 April 2010 2010-04-14T21:00:00Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 06:00, 15 April 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td> <td colspan="2" class="diff-lineno">Line 7:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010033</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-oxo-15R-hydroxy-prostsa-10,13E-dien-1-oic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-oxo-15R-hydroxy-prostsa-10,13E-dien-1-oic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2<del style="font-weight: bold; text-decoration: none;">&amp;&amp;9-oxo-15R-hydroxy-prostsa-10,13E-dien-1-oic acid</del>&amp;&amp;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;13,14-dihydro-15-keto Prostaglandin A_2&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin.[[Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933|{{RelationTable/GetFirstAuthor|Reference:Granstrom_E:Hamberg_M:Hansson_G:Kindahl_H:,Prostaglandins,1980,19,933}}]][[Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917|{{RelationTable/GetFirstAuthor|Reference:Fitzpatrick_FA:Aguirre_R:Pike_JE:Lincoln_FH:,Prostaglandins,1980,19,917}}]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> </table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53252&oldid=prev Editor at 10:00, 25 February 2010 2010-02-25T10:00:10Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <tr class="diff-title" lang="en"> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 19:00, 25 February 2010</td> </tr><tr><td colspan="2" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr></table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53251&oldid=prev Editor at 14:00, 19 February 2010 2010-02-19T14:00:10Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <tr class="diff-title" lang="en"> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td> </tr><tr><td colspan="2" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr></table> Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20210PG01&diff=53250&oldid=prev Editor at 14:00, 19 February 2010 2010-02-19T14:00:00Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <tr class="diff-title" lang="en"> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td> </tr><tr><td colspan="2" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr></table> Editor